Literature DB >> 2167734

The effects of granisetron, ICS 205-930 and ondansetron on the visceral pain reflex induced by duodenal distension.

H E Moss1, G J Sanger.   

Abstract

1. Distension of the duodenum in anaesthetized rats, by rapid application of intraluminal pressures (10-75 cmH2O), evoked falls in diastolic blood pressure and intragastric pressure. 2. The distension-induced responses were blocked by pretreatment with morphine (20 mg kg-1, s.c.), an action reversible by injection of naloxone (5 mg kg-1, i.v.). 3. Bilateral cervical vagotomy reduced the distension-evoked fall in intragastric pressure but had no effect on the corresponding fall in blood pressure. 4. Granisetron or ICS 205-930 (1-1000 micrograms kg-1, i.v.) had no effects on duodenal intraluminal pressure, but reduced the responses to distension with a bell-shaped dose-response relationship. Ondansetron (1-1000 micrograms kg-1, i.v.) did not reduce the reflex responses. 5. These results show that the 5-HT3 receptor antagonists used exerted different effects on the reflex responses to duodenal distension.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167734      PMCID: PMC1917769          DOI: 10.1111/j.1476-5381.1990.tb15836.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Quantitative determination of the visceral pain threshold in man; characteristics of visceral pain, effect of inflammation and analgesics on the threshold, and relationship of analgesia to visceral spasm.

Authors:  E A GAENSLER
Journal:  J Clin Invest       Date:  1951-04       Impact factor: 14.808

2.  Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.

Authors:  A Butler; J M Hill; S J Ireland; C C Jordan; M B Tyers
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

3.  Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy.

Authors:  M G Kris; R J Gralla; R A Clark; L B Tyson
Journal:  J Clin Oncol       Date:  1988-04       Impact factor: 44.544

4.  Visceral pain reflex after pretreatment with capsaicin and morphine.

Authors:  F Lembeck; G Skofitsch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000

5.  5-Hydroxytryptamine release into dog intestinal vasculature.

Authors:  T F Burks; J P Long
Journal:  Am J Physiol       Date:  1966-09

Review 6.  New antiemetic drugs.

Authors:  G J Sanger
Journal:  Can J Physiol Pharmacol       Date:  1990-02       Impact factor: 2.273

7.  Opiate-induced inhibition of the visceral distension reflex by peripheral and central mechanisms.

Authors:  S J Clark; T W Smith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

8.  Irritable bowel syndrome: a test of the colonic hyperalgesia hypothesis.

Authors:  P Latimer; D Campbell; M Latimer; S Sarna; E Daniel; W Waterfall
Journal:  J Behav Med       Date:  1979-09

9.  Mechanical visceral pain model: chronic intermittent intestinal distention in the rat.

Authors:  R W Colburn; D W Coombs; C C Degnan; L L Rogers
Journal:  Physiol Behav       Date:  1989-01

10.  Intestinal distension test, a method for evaluating intermittent visceral pain in the rabbit.

Authors:  F M Jensen; J B Madsen; C V Ringsted; A Christensen
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

View more
  20 in total

Review 1.  Visceral perception: inflammatory and non-inflammatory mediators.

Authors:  L Bueno; J Fioramonti
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 2.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 3.  Granisetron. A review of its pharmacological properties and therapeutic use as an antiemetic.

Authors:  G L Plosker; K L Goa
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

4.  Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK.

Authors:  W E Whitehead; M Delvaux
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

Review 5.  New developments in the treatment of functional dyspepsia.

Authors:  Vincenzo Stanghellini; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Cesare Tosetti; Roberto Corinaldesi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Experimental colitis alters visceromotor response to colorectal distension in awake rats.

Authors:  O Morteau; T Hachet; M Caussette; L Bueno
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

7.  Current insights in to the pathophysiology of Irritable Bowel Syndrome.

Authors:  Theodoros Karantanos; Theofano Markoutsaki; Maria Gazouli; Nicholas P Anagnou; Dimitrios G Karamanolis
Journal:  Gut Pathog       Date:  2010-05-13       Impact factor: 4.181

Review 8.  Role of serotonin in the pathophysiology of the irritable bowel syndrome.

Authors:  Michael D Crowell
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

9.  Mechanosensitive duodenal afferents contribute to vagal modulation of inflammation in the rat.

Authors:  Frederick Jia-Pei Miao; Paul G Green; Jon D Levine
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

Review 10.  Serotonergic modulation of visceral sensation: upper gastrointestinal tract.

Authors:  J Tack; G Sarnelli
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.